drugs. Liposomes also have an important immunoadjuvant activity. They can, therefore, be employed carrying cell-surface tumour antigens to induce antitumour responses.
The application of liposomes to antitumour treatment is now made more practicable by the introduction of simple and mild procedures for the preparation of liposomes and the incorporation of drugs within them. Also it is now possible to prepare targeted liposomes by the covalent coupling of cellspecific ligands.
There is some potential for the use of liposomes in tumour detection as well as for therapy. Dr R H J Begent of Charing Cross Hospital described how liposome entrapped second antibodies (LESA) are directed against the first antitumour antibody which is not tumour bound. LESA are then cleared by the reticuloendothelial system. This LESA-accelerated clearance of radiolabelled first antibody (carcinoembryonic antigen) has been shown to enhance the gamma-camera imaging in patients with gastrointestinal cancer.
Finally, the meeting dealt with the question of the association between lipoproteins and cancer. Epidemiological studies on the incidence of cancer in inter-country populations show an association between high serum cholesterol concentrations and a high incidence of cancer. However, studies within defined populations show a relationship between hypocholesterolaernia and cancer risk. The causeeffect relationship is not clear. In some leukaemic patients it appears that the hypocholesterolaemia is associated with an increase in low-density lipoprotein (LDL) receptors, LDL uptake and degradation by leukaemic cells. This kind of relationship has also been found by Dr C Peterson of the Karolinska Institute, Stockholm, for crude homogenates of breast cancer tissue. There was an inverse relationship between LDL receptor concentration and prediction of survival after surgery, especially if this information was used with other prognostic data.
The possibility is being explored by both Dr Peterson and Dr J Shepherd (Royal Infirmary, Glasgow) that LDL may be used as carrier for lipophilic antitumour drugs. LDL may be taken up by specific receptors and is not susceptible to the resistance mechanisms and allergic responses observed with other systems. On the other hand, LDL uptake does not show a high degree of organ specificity, so it may be necessary to suppress its uptake by gonadal tissues with hydrocortisone. Experiments with animal models show some promise, but more work needs to be done.
The meeting therefore covered many aspects of lipids in relation to tumours. Clearly this is an area capable of greater development and the meeting looked forward to hearing of more progress in the ensuing years. Since 1978, the survival rate for babies born at over 30 weeks' gestation has been near 100%. In that year the rate for babies born at 28 weeks was 50%; this 50% mark has now descended to 25 weeks and a few have survived at the age of23 weeks, but none below that. Quoting figures differently expressed, from a survey in Avon, Dr Harvey pointed out that the fact that between 1976 and 1980 the 'live' births of babies weighing under 1000g had apparently increased fourfold meant, essentially, that many more of these babies were now regarded as salvageable than had been the case formerly. A survey from the Australian state of Victoria, carried out in specialized centres for the premature in the period 1979-80, indicated that 29% of the under 1000g babies were surviving, while the rate was only 17% for ordinary hospitals. This was in spite of the fact that the specialized centres tended to get the most problematic babies; their rate of producing handicap-free babies was also better.
K R Bruckdorfer
This, Dr Harvey indicated, was the heart of the problem: tiny babies are very easily damaged -even by procedures that would not damage a larger infant. Brain haemorrhages are common in the very premature; these can lead to profound deafness or mental handicap. There is also a risk of cysts developing. This is why, as late as the immediate post-War period, most premature babies either died or grew up handicapped. Today the numbers of those who survive and grow up healthy are similar to those who used to die, but a belt of handicap remains. The most recent figures, for 1986, show that at 28 weeks' gestation 72% survived; only 15% of these are thought to be handicapped, and only half of these with a major handicap.
As a warning against the folly of too-indiscriminate use of intensive facilities, Dr Harvey showed a slide of a well-nourished 3-year-old being maintained on a ventilator in a hospital in Japan. He had been born there, very premature, and was profoundly damaged, but no one had apparently thought to turn off the machine. He said he felt it was partly because parents were aware that such mistakes might be perpetrated, but also too because they sometimes had an out of date pessimism about their child's chances, that they tended to say to him, 'You won't do too much, doctor, will you?' The critical times for telling parents what to expect, and gauging their views, were when the birth was imminent, after resuscitation and when the baby was about a week old.
Dr Deborah Rosenblatt, a psychologist at Queen Mary's Hospital who works with the staffand parents of babies in the intensive care unit, said that she thought that special units could be of great benefit not only to babies and parents but also to staff, in terms of job satisfaction. She would like to see the specialized care procedures taking more notice of the babies' emotional needs -and also the needs of the mothers who had to learn to care at home for the babies they had not originally expected to survive. Matters had improved over the years, for instance parents were now much more often allowed to stay in the unit and participate, but more could be done. The birth of a premature baby was commonly a crisis of growth for the parents and, in general, units did not pay enough attention to parents' other or practical problems. It is common for children who have been very premature to show later signs of residual neurological damage, but the picture tends to be complicated by higher than average rates of neglectful or generally poor parenting, suggestive of an initial failure to bond with the baby. Dr Rosenblatt was properly cautious in her use of the word 'bond' in this context.
In special units, overwork and the stress of the job lead to staff absenteeism: Dr Rosenblatt felt that some opportunities for spreading the workload were missed and that, in general, more thought needed to be put into organization. The funding brief was too narrow: money would be well spent on more social work with the rather poor families who frequently have these tiny babies, and on transitional care in the home -particularly for mothers with other children to look after. She also felt that grants might be appropriate to some of the voluntary groups who provide support and solace to the parents of damaged children and thus take the load off the medical services.
The ethical issues involved in salvaging tiny babies, said Dr Rosenblatt, are delicate and almost impossible to codify. If you begin to talk in terms of a formal cut-off point below which intensive care is not given -24 weeks gestation? 800 g birthweight? -you find yourself edging into areas of unacceptable selection. We can hardly tell high-risk groups not to have babies. Many low birthweight babies are born to teenage, working class mothers, often with no partners. Sometimes, in practice, it is the mother who is allowed to decide how great an effort is made with any particular child.
The third speaker, Richard Stevenson of Liverpool University, remarked that, as an economist, he was traditionally cast as the villain of health provision. Taking up Dr Rosenblatt's words about cutoff points, he said that the science of economics commonly demanded such codified rules -though it was a measure of medical advance that any 'rules' had constantly to be revised: he now heard discussions of the desirability of ventilating babies born at under 700g, whereas three years earlier 1000g had usually been given as a baseline (900 in the USA). He went on to speak of an ongoing study in Liverpool, begun in 1979, of babies born at less than 1500g. These had been divided into two groups, those over 1000g and those under. The earliest children in the study had already been followed up at the age of 4, and rough projections had been made of the lifetime monetary costs of looking after the most handicapped. Overall findings seemed to indicate that scarce resources were better concentrated on heavier babies, but this was so only in broad, average terms; there was no reliable relationship between birthweight and outcome in individuals. Nor were the data any more useful when expressed in terms of weeks' gestation. The best predictors had been found, after all, to be clinical symptoms, but no single discriminate, said Mr Stevenson, was ever adequate: 'You can't decline to treat someone just because he's not big enough'. In general, the best 'rules' were probably those that engaged the interest and self interest of the intelligent agents, i.e, the doctors, since economic efficiency was to do with input and output.
To illustrate what he meant about the fallibility of rule-logic, he suggested that it would theoretically be just as defensible to have rules based on equity. By guidelines such as these, all premature babies would, for example, get three days' ventilation, regardless of their state, no less and no moreand, extending the fantasy, kidneys for transplants would be awarded by lottery! Such 'fair' allocation of resources was demonstrably not efficient in practice.
Allocation of resources, and the need for a social consensus on the subject, was taken up again as soon as the meeting was thrown open to questions from the floor. The Chair, the Rt Hon Renee Short, MP, spoke of the Conservative Party's defence budget. Then Dr Rosenblatt, who is Canadian, made an interesting point about the passivity of British NHS patients and their families compared to transatlantic ones, mentioning that the parents of sick babies make poor consumer pressure groups -they tend to be too preoccupied, or too grateful.
Dr Harvey said that, in his experience, all neonatal units tend to suffer from a shortage of specially trained staff and he invited views on whether this is because we do not train enough in the first place or because they leave -and whether this is due to the stress of the job or other material factors? Should there be special inducements offered? A neonatal nurse in the audience said that she did not think this was a problem peculiar to her own group; all nurses suffered problems over pay and the cost of big city accommodation. There was no reason for neonatal nurses to be paid more than nurses in any other specialty and, as for stress, she had chosen this branch of nursing because she liked the challenge and supposed that others had too. Mr Stevenson made the point, endorsing one of Dr Harvey's initial statements, that while elaborate equipment may look expensive it actually accounts for only about 15% of the budget in a special neonatal unit; the bulk of the cost is in nursing. In response to a direct question, he said that it costs about £300 a day to keep a premature baby in intensive care, i.e. on a ventilator, but only about half that for special care (monitoring, intravenous feeding, etc). Care without these extras is about £80 a day. It was agreed that figures for adult intensive care are considerably higher. But Mr Stevenson pointed out that, once again, one must beware of apparently straightforward economic argument, even one based on the 'qually' (qualityadjusted life year). There was, he said, an overriding principle that 'care' is a club to which we all have some right of access, though it may be disputed that the right cannot be boundless. It would be rather hard to say to a previously healthy man of70 in need of intensive care, 'Sorry, but your qually rating isn't good enough'. However, it was generally agreed that the strongest case can usually be made out for the care of the young.
Other questioners 'touched on the need for more advice for mothers in at-risk categories, particularly those who have had previous premature births or miscarriages. Dr Rosenblatt made the point that while the prevention argument is always attractive, we do not on the whole know what causes premature births. It was asked if more research money should be allocated to this, and Dr Harvey replied that the research should come first and the resources afterwards. He agreed that there was too much separation of obstetric and neonatal care, but felt that such problems were often best overcome on the spot by the senior staff concerned getting together.
This was a stimulating and useful discussion, with each of the main speakers being cogent and informative in their own field. It seems on reflection, however, rather a pity that the statistics cited all related to the United Kingdom, with a brief excursion into the Commonwealth. Since there has been criticism in recent years of Britain's success rate with neonates, not in comparison with her own past but in comparison with other EEC countries, it might have been illuminating ifthis aspect ofthe subject had also been raised. 
Gillian

The philosophy ofcompensation
Professor Patrick Atiyah (Professor of English Law, Oxford) stated that law is based on the concept of fault. Lawyers stress that it is not a moral concept but lay people may think it is. He pointed out that in attributing blame, the legal definition of fault is the absence or failure to use reasonable care or skill. Reasonableness in the legal context is judged objectively. This does not mean perfection or total absence of mistakes, and the wrong treatment is not necessarily negligence. In some cases judges have to decide which of two medical witnesses is right, but that is different from adjudicating between two schools of thought, The standard ofskiU to which a patient may be entitled varies, Levels of reasonableness must be identified. Doctors may be accused of negligence when they do not think they have done wrong. It was stressed that judges in Britain are generally sympathetic to the medical profession in, medical negligence, as compared with judges in the United States. They are aware that it is easy to be wise after the event.
How then are damages and compensation calculated? In Britain they are generous once the legal fault is proved. Professor Atiyah pinpointed the three main heads of damages: (1) Potential lost earnings attributable to the injury. (2) Cost of medical and nursing expenses; this may be assessed on a private basis. (3) Non-pecuniary loss, i.e, pain and suffering; this includes discomfort and loss of amenities. It would seem that people buy insurance on a fault basis. It would not be too difficult to develop a no-fault system. The question arose whether there should be a no-fault compensation scheme in Britain. Such a scheme exists, for example, in Sweden, but the Swedes have a problem in their definition of medical misadventure. He concluded that the system is unlikely to change in Britain in the near future unless the initiative comes from the medical profession.
America tomorrow
Dr David Youel (Professor of Medicine, American University of the Caribbean) referred to the fact that many lawyers in the United States specialize in medical malpractice and some in one particular specialty of medicine. Medical malpractice suits are common in the United States: there were 2.5 per 100physicians in 1976,and this rose to 16 per 100 in 1984. The average award for those cases going to trial was $420000 in 1978,and increased to $8BO 000 in 1983. Out of 100 suits filed, 50 are dismissed, 40 settled by private agreement and one in 10 goes to trial. Lawyers receive 40-50% of the settlement. The patient is the
